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Variations in Arterial Blood Pressure 
after Kidney Transplantation 
Relation to Renal Function, Plasma Renin Activity, 
and the Dose of Prednisone 
By MORDECAI M. POPOVTZER, M.D., WULF PINNGGERA, M.D., FRED H. KATZ, M.D., 
JACQUES L. CORMAN, M.D., JOHN ROBINE'ITE, B.Sc., BERNARD LANOIS, M.D., 
CHARLES G. HALGRIMSON, M.D., AND THOMAS E. STARZL, M.D., PH.D. 
SUMMARY 
The course of hypertension within the first 2 months after kidney transplantation was corre-
lated with renal function, plasma renin activity (PRA), and the daily maintenance dose of 
prednisone in 18 homograft recipients. During acute rejection blood pressure (BP) closely cor-
related with PRA. Patients with normal homograft function showed an increase in BP early 
after transplantation which in most returned to normal 3-8 weeks later. In the latter group no 
correlation could be found between the level of BP and PRA, however the BP correlated close-
ly with the dose of prednisone. These observations suggest that during acute rejection the in-
crease in BP may at least partly be mediated by a renal pressor mechanism, whereas with normal 
renal function the high dose of glucocorticoids may play an important role in the development 
of hypertension. 
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HIGH BLOOD PRESSURE is a common 
phenomenon after kidney transplantation.I - 8 
In view of its potential detrimental consequences9-11 
effective control of posttransplant hyptertension is 
of utmost importance.1o Numerous factors have 
been implicated as either causing or contributing 
to the occurrence of hypertension early after kidney 
transplantation.5. 7. 12. 13 Renal pressor mechanism 
may be responsible for high blood pressure in states 
of impaired homograft perfusion resulting from 
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prolonged ischemia timel2. 14. 15 or renal artery 
stenosis.16• 18 Hypertension which occurs during 
acute rejection has been reported to resemble renal 
arterial hypertensionll• 19 and is frequently associat-
ed with a high plasma renin activity.15. 20. 22 
Retained diseased kidneys have been proposed as 
another factor responsible for high blood pressure.23 
Reports on cure of hypertenSion after removal of 
the residual organs lend support to this notion, 
although the mechanism is poorly understoodp·23 
In a reported series of hypertensive renal 
homograft recipients, normotension was noticed to 
prevail as time elapsed and the dose of corticoids 
was reduced.24 This observation implied a possible 
cause and effect relationship between the level of 
blood pressure and the dose of steroids and 
warranted a more detailed appraisal of the role of 
glucocorticoids in posttransplant hypertenSion. Ob-
servations on the early course of hypertenSion after 
transplantation, its relation to the variations in renal 
function, plasma renin activity, and the dose of 
glucocorticoids, form the basis of the present 
communication. 
--- ------~----- ------------------
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Table I 
Clinical Data and Plasma Renin Activity of All Patients 
BP PRA 
Pt Age (yr) Bilat (mm Hg) (ng/ml/hr) Sex Diagnosis Hemodialysis NPX Pre-NPX Post-NPX Pre-NPX Post-NPX Donor 
CB 40 F ChrGN + + 140/100 120/70 10.82 0.00 R 
RC 41 F ChrGN + 200/110 9.11 H 
BW 28 lVI ChrGN + + 160/100 140/90 1.80 0.49 R 
UM 16 F ChrGN + + 180/120 120/80 R 
MK 18 F Chr GN + + 170/120 150/90 4.20 0.00 R 
KR 46 I'll Chr GN + 160/110 9.27 R 
PJ 28 F Chr rej + 160/100 3.00 C 
WM 42 F ChrGN + + 140/100 120/80 0.44 R 
NJ 10 F MedCD + 140/90 1.80 C 
TS 12 F Chr rej + 140/110 7.50 C LL 16 F I.E neph + + 180/110 120/70 114.00 0.00 R 
VJ 14 I'll Med CD 130/90 R 
LN ;~U F ChrPN + 180/110 C 
DP 9 F Cyst + 140/100 C 
ML 28 I'll Chr GN + 170/118 R 
DJ 23 M Chr rej + 160/100 11.70 C 
CM 24 F Chr GN 140/100 R 
CE 18 M ChrGN + + 160/110 145/80 0.00 R 
Abbreviations: Chr GN = chronic glomerulonephritis; Med CD = medullary cystic disease; Chr rej chronic rejection of 
homograft; I.E neph = lupus nephropathy; Chr PN = chronic pyeleonephritis; Cyst = cystinosis; Bilat NPX = bilateral nephrec-
tomy prior to transplant; BP = blood pressure; PRA = pla;,ma renin activity; R = related; C = cadaver; BP = blood pressure. 
Methods 
Fifteen patients with chronic renal disease of diverse 
etiology and three patients with chronic rejection of 
renal homo grafts undergoing transplantation were 
studied. Sixteen patients had diastolic blood pressure in 
excess of 90 mm Hg. The sex, age, and the source of 
the organs are listed in table 1. Seven patients 
underwent bilateral nephrectomy 1-6 months prior to, 
and six during the transplantation; five retained their 
original kidneys. The surgical procedure and the 
immunosuppressive regimen were described elsewhere 
in detai1.25,26 Sixteen patients were treated with 
chronic hemodialysis. All patients were on a low-protein 
diet ( 40g/ 24hr), and the amounts of sodium and 
Table 2 
Creatinine Clearances, Blood Pressure, Body Weight, Urinary Sodium Excretion, Plasma Renin Activity, and Daily 
Maintenance Dose of Prednisone during the First Week and 3-8 Weeks after Kidney Transplantation in Patients 
with Adequate Renal Function 
C CR BP Weight UNA V PRA Prednisone 
(ml/min) (mm Hg) (kg) (mEq/24 hr) (ng/ml/hr) (mg/24 hr) 
Pt I II II II I II I II I II 
UM 45 68 160/120 120/60 41 45 140 152 4.00 18.10 140 30 
RC 40 38 160/100 140/90 45 49 110 130 11.00 1.9 120 45 
MK 65 70 160/120 126/70 44 42 135 130 1.44 5.00 200 40 
CE 69 80 150/110 130/70 55 57 105 120 1.20 2.41 170 4.'; 
BW 60 62 160/110 140/100 59 58 147 132 0.50 .5.90 180 90 
WM 70 68 140/90 110/80 43 46 140 155 1.10 7.30 ]40 45 
TS 29 63 160/115 110/70 43 41 142 121 0.00 2.30 180 2.5 
DJ 46 50 140/100 130/80 60 .55 100 122 0.50 12.20 17,,) 40 
CM 56 48 140/100 100/64 52 .'50 140 120 0.22 2.50 180 40 
LL 50 46 120/70 110/70 .'i5 .56 130 150 0.60 1.12 40 30 
VJ* 42 51 170/10.5 140/90 40 .52 100 104 17.90 80 15 
KR* 8.5 77) 180/110 140/80 62 65 150 170 14.00 170 40 
ML* 36 46 160/110 150/100 80 77 160 152 20.0 38.40 180 100 
JP 49 .52 130/95 120/80 43 47 159 167 1.80 170 50 
*Patients retaining their original diseased kidneys. 
Abbreviations: C CR = creatinine clearances; UNA V = urinary sodium excretion; I = first week after transplant; II = 3-8 weeks 
after transplant. 
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potassium were adjusted according to the individual 
needs of each patient. After transplantation, patients 
with adequate homograft function were given liberal 
diets. The calculated amounts of sodium in the diets 
ranged from 100 to 170 mEqJ 24hr; these amounts were 
also reflected in urinary excretion rates as shown in 
tables 2 and 3. Salt and water intake were restricted 
only during acute rejection. All patients were weighed 
daily. 
Kidney Function 
Endogenous creatinine clearances were used as 
estimates of glomerular filtration rate. Urine was 
collected over 24 hours and blood was obtained at the 
end of the collection periods. Creatinine concentrations 
in the serum and in the urine were determined with a 
Technicon autoanalyzer. Creatinine clearances were 
measured daily during the first 4-6 weeks after surgery 
and then at least once every week; during episodes of 
acute rejection, the clearances were measured daily. 
Sodium concentrations in the serum and in the urine in 
all specimens were determined with an Instrumentation 
Laboratory flame photometer model 143. 
Blood Pressure 
Blood pressure was measured in supine position four 
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to eight times daily during the first 4-6 weeks after 
surgery and thereafter at least once a week. During 
acute rejection crises, it was recorded as frequently as 
during the initial period. The values to be given 
represent averages of daily measurements. 
Plasma Renin Activity 
Eighty-five determinations of plasma renin activity 
(PRA) were made during the study; 18 before and the 
remainder after surgery. Blood collected directly into 
EDT A-containing vacutainer tubes was spun in a 
refrigerated centrifuge and the plasmas were frozen. 
The patients were in a supine position for at least 1 
hour before the blood was withdrawn. The measure-
ments of PRA were performed with a radioimmunoas-
say.27, 28 In most of the patients, PRA was determined 
on two occasions; first, during the first week, and 
second, 3-8 weeks after transplantation. The dietary 
sodium intake on these two occasions was very similar; 
this fact is also reflected in comparable urinary excre-
tion rates of sodium as shown in tables 2 and 3. 
Additional determinations were made within the course 
of the study. In several patients, serial values were 
obtained following bilateral nephrectomy and after 
surgical removal of the rejected homografts. 
Table 3 
Average Antihypmensive Therapy during the First Week and 3-8 Weeks after Kidney Trafl8-
plantation in Patients with Adequate Kidney Function 
Methyldopa Reserpine Hydralazine Guanethidine Hydrochlorothiazide 
Pt Time (mg/24 hr) (mg/24 hr) (mg/24 hr) (mg/24 hr) (mg/24 hr) 
r~1 I 750 100 50 
II 50 
RC I 500 0.50 80 100 
II .'lOO 0.50 40 100 
MK I 1000 0.7.') 100 100 
II 500 0.;')0 100 
CE I 1000 0.75 120 10 1.50 
II 1000 0.7.5 1.50 
BW I 1:iOO 80 20 1;)() 
II 1500 0.:')0 80 20 150 
WM I 500 60 100 
II 50 
TS I 750 100 100 
II 500 100 
DJ I 750 0 .. 50 80 100 
II 500 0.50 100 
CM I 1000 0.50 60 50 
II 500 50 
LL I 
.50 
II 
VJ I 750 0.75 80 150 
II 7.50 1.00 SO 150 
KR I 1500 1.00 20 100 
II 750 0.50 20 100 
ML I 1000 1.00 60 150 
II 1000 1.00 60 150 
JP I 500 100 
II 500 100 
Abbreviations: I = first week after transplant; II = 3-8 weeks after transplant. 
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Antihypertensive Therapy 
Antihypertensive therapy after transplantation was 
instituted in every patient with a diastolic blood 
pressure exceeding 90 mm Hg. This approach was 
adopted as a safeguard against the detrimental renal 
effect of severe hypertension. The antihypertensive 
regimen was based on the following agents: hydrochlo-
rothiazide, reserpine, methyldopa (aldomet), hydrala-
zine, and guanethidine. The combined dose (usually 
several drugs were used at the same time) varied in 
relation to the severity of hypertension, and was 
reduced or discontinued as blood pressure returned to 
normal; thus, during the latter part of the study the 
combined dose of various antihypertensive agents was 
considerably lower than that employed initially; 
however, the dose of diuretics (hydrochlorothiazide) 
did not change throughout the study. 
Immunosuppression with Glucocorticoids 
after Transplantation 
Prednisone was given initially in the amount of 
100-200 mgj24hr. Only in one patient (L.L.) in the 
initial dose was 40 mgj 24hr. The dose was reduced 
gradually after surgery. A high dose was reinstituted 
during episodes of acute rejection. In several patients, 
corticoids were also given for several days before 
surgery. 
Results 
Kidney Function 
Fifteen patients had adequate renal function 
after transplantation (tables 2 and 3). In patient 
D.P. (not listed in tables 2 and 3) the homograft 
functioned only for 1 week. Three patients (N.J., 
L.N., and e.B.) underwent accelerated acute 
rejection shortly after surgery and the homo grafts 
were removed within the first postoperative week. 
Episodes of acute rejection occurred in another five 
patients (R.e., B.W., C.M., M.K., and K.R.) during 
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a later part of the study. In M.K., acute rejection 
led to a total infarction of the homograft with renal 
vein thrombosis; the remaining four patients 
recovered and regained normal renal function. The 
diagnosis of acute rejection was based on clinical 
and biochemical findings in five and on tissue 
histology in four patients. 
Blood Pressure 
All patients who underwent bilateral nephrecto-
my prior to transplantation showed a decrease in 
blood pressure (table 1). Hypertension (diastolic 
pressure 90 mm Hg) was present in most of the 
patients early during the first week after transplan-
tation (tables 2 and 3). Blood pressure increased 
during acute rejection in seven patients, did not 
change in one, and fell in one (B.W.); in the later 
septicemia could account for the observed hypoten-
sion (table 4). 
Prednisone· and Blood Pressure 
Five of six patients who were treated with 
prednisone for a short period of time prior to 
transplantation showed an increase in blood pres-
sure (table 5). The latter was not associated with 
substantial changes in body weights. Five patients 
were anephric. These patients were treated with 
hemodialysis three times (8-hr intervals) a week 
with a Kiil-type hemodialyzer. The listed weights 
and blood pressure levels were measured before 
dialysis. The patients were not on antihypertensive 
therapy during the observation period. 
All patients with adequate kidney function 
showed a decrease in blood pressure as the dose of 
glucocorticoids was reduced. Table 2 lists the levels 
Table 4 
Plasma Renin Activity before and during Acute Rejection 
BP Weight PRA 
Pt 
(mmHg) 
II 
(kg) (ng/ml/hr) 
II II 
CB* 140/100 150/110 47.0 49.0 20.1 69.9 (142.0)t 
NJ* 150/100 190/140 26.0 25.;'') 28.8 148.8 
LN* 140/90 140/110 49.0 42.0 3.9 25.7 
He 140/100 HiO/ll0 42.0 52.0 1.9 26.6 
DP* 140/90 150/105 14.0 15.8 14.0 20.1 
CM 140/9.'> 140/95 51.0 53.0 0.22 2.5 
BW 170/105 90/riO 53 .. 5 52.0 5.9 15.6 
KR 130/90 140/115 62.0 66.0 9.0 32.0 
MK 126/70 140/100 36.0 41.0 0.62 0.60 
*In these patients acute rejection st.arted shortly after transplantation; adequate homograft function was 
never reached. 
tPltA value after hemodialysis. 
Abbreviations: I = before rejection; II = during rejection; BP = blood pressure; PRA = plasma renin 
activity. 
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Table 5 
Changes in Blood Pressure following the Administration of Prednisone P'rior to Transplantation 
BP Weight 
Prednisone 
(mmHg) (kg) 
Pt (mg/24 hr) Days NPX Pre Post Pre 
Post 
CB 200 2 + 120/70 160/110 49.2 49.0 
BW 200 2 + 130/50 180/120 59.0 59.4 
UM 100 2 + 130/86 148/100 43.S 42 .. 5 
KR 200 3 130/90 180/120 67.0 66.0 
WM 200 3 + 120/80 170/112 49.0 48.6 
CE 100 S + 140/80 140/80 S8.0 .56.0 
Abbreviations: Days = days of treatment with prednisone; NPX = after bilateral nephrectomy; Pre = 
measurement obtained prior to administration of prednisone; Post = measurement made after administration 
of prednisone, before transplantation. 
of blood pressure in the first postoperative week 
when the patients were on the peak dose of steroids 
and at a later period (3-8 weeks after surgery) 
when the dose was reduced to its lowest value. The 
blood pressure levels recorded initially were higher 
than those measured later. Patients who were still 
on large amounts of prednisone (B.W. and M.L.) 
during the latter period showed elevated blood 
pressure. In figure 1, the doses of prednisone were 
plotted against diastolic blood pressure values in 
patients with adequate renal function (the diagram 
contains measurements of blood pressure at three 
different doses of prednisone and in one patient at 
four different doses, episodes of acute rejection 
were not included). A highly significant direct 
correlation was found between those two variables. 
Doses of prednisone divided by body weights were 
plotted against blood pressures. The relationship 
between these two variables was similar to that 
noticed in figure 1 (r= 0.72). Similar plot for blood 
pressure and body weight showed no significant 
correlation. 
Plasma Renin Activity 
Plasma renin activity values measured in a group 
of normal subjects under varying conditions of 
posture and salt intake are shown in table 6. Since 
most of our patients after transplantation were 
treated with antihypertensive agents which might 
have affected PRA,28.29 the interpretation of the 
results is complicated and great caution has to be 
exercised in arriving at definite conclusions. Antihy-
pertensive therapy was reduced substantially dur-
ing period II as compared with that during period I 
(table 3). However, the dose of hydrochlorothia-
zide was not altered and thus could not contribute 
to the observed changes in PRA. Methyldopa 
decreases whereas hydralazine increases PRA;28. 29 
both drugs were reduced during the latter period of 
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the study. The effect of this alteration in therapy on 
PRA is difficult to quantitate, however presumably 
it was minimal, considering the opposite influences 
of methyldopa and hydralazine on PRA. 
Following bilateral nephrectomy (before trans-
plantation) in six patients, PRA was undetectable in 
four and below 0.5 ng/ml/hr in two (table 1). 
Serial determinations of PRA in a patient with 
lupus nephropathy (L.L.) after bilateral nephrec-
tomy are shown in table 7. During the first week 
after transplantation, the PRA in the majority of 
patients with adequately functioning homografts 
was low or normal (table 2). These values were 
recorded at the time when most of the patients 
were hypertensive. PRA values measured 3--8 weeks 
after transplantation were higher than the initial 
ones in all but one. These values were obtained 
when most of the patients were normotensive and 
the amount of antihypertensive agents was marked-
ly lower than that given initially during the first 
DIASTOLIC 
B.P.(mm Hg) 
120 
100 
80 
60 
0 
UMOb~ 
0 
b= 0.21 
r = 0.74 
P <0.001 
20 40 80 120 160 200 
PREDNISONE (mg/24hr.) 
Figure 1 
The relationship between diastolic blood pressure and the 
maintenance dose of prednisone in patients with adequate 
kidney function. 
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Table 
PRA in Normal Sub;ects 
110 mEq/24 lir 
Data Supine 
Mean (ng/ml/hr) 1.60 
SF] (ng/ml/hr) 0.40 
N 9 
P <0.02,') 
RUllge (ng/ml/hr) 0.2:3-3.62 
weeks. Three of five patients with PRA exceeding 
10 ng/ml/hr (K.R., V.J., and M.L.) had retained 
their original damaged kidneys. The changes in 
body weight and in sodium excretion were relative-
ly small and inconsistent. No significant correlation 
could be found between diastolic blood pressure 
and PRA in patients with normally functioning 
homo grafts (fig. 2). A marked increase in PRA was 
noticed during acute rejection (table 4). These 
changes were noticed before readjustments were 
made in the dose of antihypertensive drugs and in 
sodium intake. In two patients (N.]., and E.G) 
PRA assumed extremely high levels. An additional 
increase in PRA was recorded in one patient (GB.) 
following a weight loss of 2.5 kg with hemodialysis. 
In patient M,K., PRA remained low; however, the 
removed homograft was totally infarcted. This 
patient gained 5.0 kg during the rejection crisis, and 
blood pressure was restored to normal after 
hemodialysis. PRA values during acute rejection 
crisis correlated directly with blood pressure values 
(fig. 3). Removal of rejected organs in three 
patients was followed by a drop in PRA and a 
decrease in blood pressure, Serial measurements of 
PRA and blood pressure after the removal of a 
rejected kidney in patient N.]. are shown in table B. 
In this patient, the hypertension which was 
associated with the acute rejection failed to respond 
TaMe 7 
Changes in PRA following Bilateral Nephrectomy and 
Transplantation in Patient L.L. 
PRA 
Date Time (ng/ml/lir) 
12/29/70 Pre-NX 114.50 
12/aO/70 18 hrs post-NPX 1.09 
12/81/70 86 hrs post-NPX 0.03 
1/ 2/71 96 hrs post-NPX 0.11 
2/ !l/71 Pre-TX 0.00 
2/ 8/71 4 hrs post-TX 0.60 
Abbreviations: NPX = bilateral nephrectomy; TX = 
transplantation. 
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6 
Na intake 
10 mEq/24 hr 
2 hrs up Supine 2 hrs up 
,').34 6.76 14.3 
1.28 1.35 2.1 
10 9 6 
<0.00.') <0.01 
0.61-10 2.13-13.8 9.2-20 
to a marked extracellular fluid volume depletion 
with hemodialysis but responded promptly to 
nephrectomy. 
Discussion 
The rise in PRA during acute rejection crises 
as seen in the present study confirms similar ob-
servations previously reported by other work-
ers.15, 20, 21, 23 Although an increase in blood 
pressure during acute rejection was associated with 
an increasing PRA, no such association could be 
demonstrated in patients with normally functioning 
renalhomografts. Similarly, other workers failed to 
show a definite consistency in the relation between 
the degree of hypertension and PRA after trans-
plantation.3, 30. 31 The role of a renal pressor 
mechanism, mediated by the renin-angiotensin 
system, in the genesis of hypertension during acute 
rejection requires further evaluation and cannot be 
established On the basis of presently available 
information. However, the prompt relief of severe 
hypertension following the surgical removal of the 
rejected homografts as observed in three patients, 
120 
100 
DIASTOLIC 
B.P. (mmHg) 80 
60 
r = -0,03 
p= NS 
0 
0 0 
0 
0 0 
0 
0 
0 0 
000 ~ 
0 
20 30 40 10 
PRA (ng ImllhrJ 
Figure 2 
Diastolic blood pressure and plasma renin activity in patients 
with adequate renal function. 
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o 
o 
b' 0,37 
r = 0.73 
P < a,QOI 
10 20 JO 40 50 60 70 150 
PRA (ng/ml/hr.) 
Figure 3 
The relatio1l8hip between diastolic blood pressure and plas-
ma renin activity in patients undergoing acute rejection. 
before any appreciable changes in body weight 
occurred, suggests that a renal mechanism was at 
least partly responsible for the severe hypertension. 
Salt and water retention is common during acute 
rejection and may contribute to the development of 
hypertension32 as observed in patient M.K.; how-
ever, in patient N.J. marked extracellular fluid 
volume depletion had no appreciable effect on the 
severe hypertension. Similar observations were also 
made in our other patients. A rise in PRA following 
hemodialysis as noticed in patient C.B., suggests 
that a homograft undergoing acute rejection 
preserves its physiologic response to extracellular 
fluid volume depletion; however, additional obser-
vations will be necessary before more definite 
conclusion can be made. The low PRA in patient 
M.K., during acute rejection, could be explained by 
the finding of totally infarcted renal homograft with 
presumably not enough viable tissue left to secrete 
the hormone. It is possible, therefore, that the 
measurement of PRA during acute rejection may 
Table 8 
Changes in PRA and Blood Pressure following Removal 
of an Acutely Rejected Homograft in Patient NJ.* 
BP PRA 
Date (1970) TiIne (mm Hg) (ng/ml/hr) 
7/19 Acute rejection 180/140 148.80 
7/24 Pre-NPX 170/135 61.30 
7/24 1 hr post-NPX 160/12.5 78.40 
3 hrs post-NPX 160/100 30.60 
4 hrs post-NPX 140/90 26.60 
12 hrs post-NPX 150/9il 18.10 
16 hrs post-NPX 164/90 13.60 
7/27 160/90 16.40 
7/29 160/100 6.60 
8/ 3 130/95 1.80 
*This patient had retained her original ditieased kidneys. 
Abbreviations: NPX = removal of rejected homograft. 
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provide certain information regarding the viability 
of the transplanted kidney. 
The variations in plasma renin activity in patients 
with adequately functioning renal homografts, 
showing an increase during the late part of the 
study 3-8 weeks after transplantation, are not well 
understood, but several possible explanations are 
worthy of comment. (1.) Although the denervated 
transplanted kidney has been shown to be capable 
of elaborating renin,33 it is quite possible that 
initially this capability is limited and improves as 
time passes. (2.) High doses of steroids which were 
given during the first week could cause suppression 
of renin production34 whereas lowering of the dose 
during the latter part of the study might have 
reversed that effect. (3.) The initial blood samples 
were obtained while the patients were on a bed rest 
regimen, whereas during the latter part of the study 
the patients were ambulatory and assumed a supine 
position only 1 hour before drawing the blood 
samples. These differences in posture could influ-
ence the results. (4.) The alteration in antihyper-
tensive regimen could exert significant effect on 
PRA.28.29 
The present observations strongly support the 
role of glucocorticoids in the development of post-
transplant hypertension. An increase in blood 
pressure presumably not associated with significant 
changes in sodium balance was observed in 
anephric patients awaiting transplantation after the 
administration of a high dose of steroids for several 
days. A significant relationship between the dose of 
prednisone and the diastolic blood pressure was 
demonstrated in patients with well functioning 
renal homografts. The reported absence of hyper-
tension in patients who are not treated with 
glucocorticoids after transplantation35 are in agree-
ment with the present findings. The possibility that 
small changes in renal function played a major role 
in altering the level of blood pressure seems 
unlikely, since no significant correlation could be 
found between creatinine clearances and the levels 
of blood pressure. 
Despite the widespread use of glucocorticoids as 
therapeutic agents in many disease processes and 
the well known occurrence of various complica-
tions, surprisingly, hypertenSion has received rela-
tively little attention.36. 37 A study undertaken to 
assess the incidence and the severity of various side 
effects associated with prolonged administration of 
glucocorticoids led to a conclusion that hyperten-
sion was not a serious complication.38 In contrast to 
the clinical observations, glucocorticoids have been 
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proved to be highly potent hypertensive agents in 
experimental animals.39 , 42 It has also been demon-
strated that hypertension which was produced 
experimentally with glucocorticoids, contrary to 
that produced with mineralocorticoids, was not salt 
dependent.39,41 The latter feature rendered the 
glucocorticoid-induced hypertension unresponsive 
to salt restriction. The animal studies also demon-
strated severe renal damage associated with gluco-
corticoid-induced hypertension.42 
The major difference between the clinical and the 
experimental conditions is related to the amount of 
glucocorticoids employed. The dose used in animals 
to induce hypertension in relation to their body 
weight was considerably larger than that usually 
used in humans. However, the doses of steroids 
which are given to patients to protect their renal 
homografts may be large enough to account for the 
hypertension. Our observation that the degree of 
hypertension was directly related to the dose of 
prednisone is consistent with that notion. Further-
more patients with renal homo grafts may differ 
from subjects with normal kidney by being more 
sensitive to the hypertensive action of prednisone. 
The recognition of glucocorticoid-induced hyper-
tension in renal homograft recipients bears on 
several important clinical aspects. The appearance 
of hypertension in patients with adequate renal 
function who are treated with large amounts of 
prednisone, early after transplantation, does not 
necessarily indicate homograft dysfunction and 
unless other signs of acute rejection are present the 
dose of immunosuppressive agents should not be 
increased. The prognosis of that kind of hyperten-
sion is usually good and a reduction of the 
maintenance dose of glucocorticoids, when possible, 
will eventually result in normotension. However, as 
long as the hypertension is present, vigorous 
antihypertensive therapy should be continued. This 
will likely minimize or prevent the deleterious effect 
of severe hypertension on the transplanted organ, 
and on the whole cardiovascular system. 
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